{
  "id": "8ebb93d5-ae0f-401e-bcc3-3d72b614fd46",
  "title": "Sana stock rallies 280% on pancreatic cell transplant study",
  "link": "https://seekingalpha.com/news/4393269-sana-stock-rallies-on-pancreatic-cell-transplant-study?utm_source=feed_news_all\u0026utm_medium=referral\u0026feed_item_type=news",
  "description": "",
  "author": "",
  "published": "Tue, 07 Jan 2025 18:38:09 -0500",
  "source": "https://seekingalpha.com/market_currents.xml",
  "categories": [
    "sana"
  ],
  "byline": "Val Brickates Kennedy",
  "length": 382,
  "excerpt": "Sana (SANA) shares rallied 270% post-market on positive results from a study of its pancreatic cell transplant therapy UP421 in the treatment of type 1 diabetes. Read more here.",
  "siteName": "Seeking Alpha",
  "favicon": "https://seekingalpha.com/samw/static/images/favicon-192x192.png",
  "text": "HealthcareOn the MoveRapidEyeShares of Sana Biotechnology (NASDAQ:SANA) rallied 270% post-market on positive results from a study of the transplantation of its allogeneic primary islet cell therapy UP421 into a patient with type 1 diabetes without the use of immunosuppression. The pancreatic cellRecommended For YouAbout SANA StockRelated StocksSANA-Trending AnalysisTrending News",
  "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/171149853/image_171149853.jpg?io=getty-c-w750",
  "html": "\u003cdiv id=\"readability-page-1\" class=\"page\"\u003e\u003cdiv id=\"content\"\u003e\u003carticle data-test-id=\"grid-container\"\u003e\u003cdiv\u003e\u003cdiv data-test-id=\"grid-col-main\"\u003e\u003cdiv data-test-id=\"card-container\"\u003e\u003cheader\u003e\u003cdiv data-test-id=\"quick-links\"\u003e\u003cul\u003e\u003cli\u003e\u003ca data-test-id=\"theme-links-item\" href=\"https://seekingalpha.com/market-news/healthcare#source=section%3Amain_content%7Csection_asset%3Athemes%7Cbutton%3Ahealthcare%7Cfirst_level_url%3Anews\"\u003e\u003cspan\u003e\u003cspan\u003eHealthcare\u003c/span\u003e\u003c/span\u003e\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca data-test-id=\"theme-links-item\" href=\"https://seekingalpha.com/market-news/on-the-move#source=section%3Amain_content%7Csection_asset%3Athemes%7Cbutton%3Aon-the-move%7Cfirst_level_url%3Anews\"\u003e\u003cspan\u003e\u003cspan\u003eOn the Move\u003c/span\u003e\u003c/span\u003e\u003c/a\u003e\u003c/li\u003e\u003c/ul\u003e\u003c/div\u003e\u003c/header\u003e\u003cdiv\u003e\u003cdiv data-test-id=\"content-container\"\u003e\u003cfigure data-type=\"getty-image\"\u003e\u003cpicture\u003e\u003cimg src=\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/171149853/image_171149853.jpg?io=getty-c-w750\" alt=\"Stethoscope rests on headlines concerning diabetes\" data-id=\"171149853\" data-type=\"getty-image\" width=\"1536px\" height=\"1024px\" srcset=\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/171149853/image_171149853.jpg?io=getty-c-w1536 1536w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/171149853/image_171149853.jpg?io=getty-c-w1280 1280w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/171149853/image_171149853.jpg?io=getty-c-w1080 1080w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/171149853/image_171149853.jpg?io=getty-c-w750 750w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/171149853/image_171149853.jpg?io=getty-c-w640 640w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/171149853/image_171149853.jpg?io=getty-c-w480 480w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/171149853/image_171149853.jpg?io=getty-c-w320 320w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/171149853/image_171149853.jpg?io=getty-c-w240 240w\" sizes=\"(max-width: 768px) calc(100vw - 36px), (max-width: 1024px) calc(100vw - 132px), (max-width: 1200px) calc(66.6vw - 72px), 600px\"/\u003e\u003c/picture\u003e\u003cfigcaption data-type=\"getty-image\"\u003e\u003cp\u003eRapidEye\u003c/p\u003e\u003c/figcaption\u003e\u003c/figure\u003e\u003cp dir=\"ltr\"\u003eShares of Sana Biotechnology (\u003cspan\u003eNASDAQ:\u003ca href=\"https://seekingalpha.com/symbol/SANA\" title=\"Sana Biotechnology, Inc.\"\u003eSANA\u003c/a\u003e\u003c/span\u003e) rallied 270% post-market on positive results from a study of the transplantation of its allogeneic primary islet cell therapy UP421 into a patient with type 1 diabetes without the use of immunosuppression.\u003cstrong\u003e \u003c/strong\u003e\u003c/p\u003e \u003cp dir=\"ltr\"\u003eThe pancreatic cell\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv data-test-id=\"recommended-section\"\u003e\u003cdiv\u003e\u003cp\u003e\u003ch4 data-test-id=\"recommended-for-you-card-title\"\u003eRecommended For You\u003c/h4\u003e\u003c/p\u003e\u003c/div\u003e\u003cdiv data-test-id=\"post-skeleton\"\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv data-test-id=\"right-rail\"\u003e\u003cdiv data-test-id=\"about-symbol-card\"\u003e\u003cdiv\u003e\u003cp\u003e\u003ch3 data-test-id=\"about-symbol-card-title\"\u003eAbout SANA Stock\u003c/h3\u003e\u003c/p\u003e\u003c/div\u003e\u003cdiv\u003e\u003cdiv data-test-id=\"about-symbol-chart\"\u003e\u003ctable data-test-id=\"table\"\u003e\u003cthead data-test-id=\"table-header\"\u003e\u003c/thead\u003e\u003ctbody data-test-id=\"table-body\"\u003e\u003c/tbody\u003e\u003c/table\u003e\u003cul\u003e\u003cli\u003e\u003c/li\u003e\u003cli\u003e\u003c/li\u003e\u003cli\u003e\u003c/li\u003e\u003cli\u003e\u003c/li\u003e\u003cli\u003e\u003c/li\u003e\u003cli\u003e\u003c/li\u003e\u003cli\u003e\u003c/li\u003e\u003cli\u003e\u003c/li\u003e\u003c/ul\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv data-test-id=\"suggested-symbols-card\"\u003e\u003cdiv\u003e\u003cp\u003e\u003ch3 data-test-id=\"suggested-symbols-card-title\"\u003eRelated Stocks\u003c/h3\u003e\u003c/p\u003e\u003c/div\u003e\u003cdiv\u003e\u003ctable data-test-id=\"table\"\u003e\u003cthead data-test-id=\"table-header\"\u003e\u003c/thead\u003e\u003ctbody data-test-id=\"table-body\"\u003e\u003ctr\u003e\u003ctd\u003e\u003ca data-test-id=\"sana-link\" href=\"https://seekingalpha.com/symbol/SANA#source=first_level_url%3Anews%7Csection%3Aright_rail%7Csection_asset%3Arelated_stocks%7Csymbol%3Asana%7Cline%3A1\"\u003eSANA\u003c/a\u003e\u003c/td\u003e\u003ctd\u003e-\u003c/td\u003e\u003c/tr\u003e\u003c/tbody\u003e\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv data-test-id=\"trending-articles-cards-container\"\u003e\u003cdiv\u003e\u003cp\u003e\u003ch2 data-test-id=\"trending-articles-cards-title\" id=\"trending-articles-cards-container\"\u003eTrending Analysis\u003c/h2\u003e\u003c/p\u003e\u003c/div\u003e\u003cdiv data-test-id=\"post-skeleton\"\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv data-test-id=\"trending-news-cards-container\"\u003e\u003cdiv\u003e\u003cp\u003e\u003ch2 data-test-id=\"trending-news-cards-title\" id=\"trending-news-cards-container\"\u003eTrending News\u003c/h2\u003e\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003c/article\u003e\u003c/div\u003e\u003c/div\u003e",
  "readingTime": "Less than 1 min",
  "publishedTime": "2025-01-07T23:38:09Z",
  "modifiedTime": null
}
